96 related articles for article (PubMed ID: 6868146)
1. [Differences between the complexes formed by monomeric fibrin with fragment D and dimer D].
Belitser VA; Platonova TN; Pozdniakova TM
Ukr Biokhim Zh (1978); 1983; 55(3):243-9. PubMed ID: 6868146
[TBL] [Abstract][Full Text] [Related]
2. [Soluble complexes of the NH2-terminal disulfide knot of fibrin with molecules containing D domains].
Pozdniakova TM; Rybachuk VN; Vovk EV
Ukr Biokhim Zh (1978); 1983; 55(6):614-21. PubMed ID: 6659078
[TBL] [Abstract][Full Text] [Related]
3. [Isolation of the fragment D dimer from stabilized fibrin and a study of its antipolymerization action].
Musialkovskaia AA; Khodorova EL; Pozdniakova TM
Ukr Biokhim Zh; 1976; 48(2):139-43. PubMed ID: 941302
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of fibrin assembly by fragment D and its dimer derived from fibrinogen and stabilized fibrin. Evidence for the two-step type of inhibition].
Platonova TN; Musialkovskaia AA; Tolstykh VM; Belitser VA
Biokhimiia; 1980 Oct; 45(10):1780-7. PubMed ID: 7236767
[TBL] [Abstract][Full Text] [Related]
5. [The role of D2-E2 centers of interdomain binding of fibrin monomer during fibrinogen co-polymerization with an NH2-terminal disulfide knot of fibrin].
Pozdniakova TM; Rybachuk VN; Ugarova TP
Biokhimiia; 1987 Apr; 52(4):592-8. PubMed ID: 3593791
[TBL] [Abstract][Full Text] [Related]
6. [alphaC domains of fibrinogen molecules as the structures accelerating fibrin assembly].
Medved' LV; Gorkun OV; Maniakov VF; Belitser VA
Mol Biol (Mosk); 1986; 20(2):461-70. PubMed ID: 3702870
[TBL] [Abstract][Full Text] [Related]
7. Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D.
Knoll D; Hantgan R; Williams J; McDonagh J; Hermans J
Biochemistry; 1984 Jul; 23(16):3708-15. PubMed ID: 6236846
[TBL] [Abstract][Full Text] [Related]
8. The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.
Edgar W; Warrell MJ; Warrell DA; Prentice CR
Br J Haematol; 1980 Mar; 44(3):471-81. PubMed ID: 7378311
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of the formation of complexes between monomer fibrin and the inhibitor of its polymerization - fragment D].
Belitser VA; Pozdniakova TM; Vovk EV; Rybachuk VN
Biokhimiia; 1983 Jan; 48(1):125-31. PubMed ID: 6830911
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of self-assembly of soluble fibrin oligomers and the role of fibrinopeptides A and B in this process].
Rozenfel'd MA; Gershkovich KB; Kuznetsov DV; Meshkov BB; Gontar' ID
Mol Biol (Mosk); 1986; 20(4):1098-110. PubMed ID: 3762532
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
12. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the stability of the intermediate fibrin polymers formed in a fibrinogen-thrombin system].
Ugarova TP; Lugovskoĭ EV; Gorkun OV; Derzskaia SG
Ukr Biokhim Zh (1978); 1983; 55(3):254-9. PubMed ID: 6868148
[TBL] [Abstract][Full Text] [Related]
14. [Molecular organization of copolymers of fibrinogen-fibrin fragment].
Rozenfel'd MA; Gershkovich KB
Mol Biol (Mosk); 1988; 22(4):923-33. PubMed ID: 3185535
[TBL] [Abstract][Full Text] [Related]
15. [Polymorphism of fibrin equilibrium oligomers in the presence of fragment D].
Gershkovich KB; Rozenfel'd MA
Mol Biol (Mosk); 1989; 23(2):596-604. PubMed ID: 2770733
[TBL] [Abstract][Full Text] [Related]
16. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of D-domain-containing specific inhibitors of polymerization on the fibrin self-assembly process].
Platonova TM; Chernyshenko TM; Sokolovs'ka LI
Ukr Biokhim Zh (1999); 2006; 78(3):124-9. PubMed ID: 17100320
[TBL] [Abstract][Full Text] [Related]
18. [Structural transformations of fibrin oligomers].
Rozenfel'd MA; Gershkovich KB; Kuznetsov DV
Mol Biol (Mosk); 1988; 22(1):86-93. PubMed ID: 3374490
[TBL] [Abstract][Full Text] [Related]
19. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
Brenner B; Francis CW; Marder VJ
J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
[TBL] [Abstract][Full Text] [Related]
20. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
